Christopher Cannon: Discontinuation vs. Continuation of Statin Therapy in Adults Aged Under 75
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, shared a post on LinkedIn about a recent article by Fabrice Bonnet, published in The Lancet Healthy Longevity, adding:
“Small randomized trial of stopping statins vs continuing in the elderly (low than 75) showed no diff in mortality but the expected trends for higher risk (about 20-30% higher) for MI stroke and MACE events).
No quality of life benefit for ‘deprescribing’.
So – best to keep the statin going!”
Title: Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial
Authors: Fabrice Bonnet, Pierre Poulizac, Nicolas Rousselot, Thierry Couffinhal, Gaël Galli, Driss Berdaï, Marie-Anne Vandenhende, Marine Rousset, Roxane Coueron, Antoine Bénard, Jean-Philippe Joseph

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis